The event featured some of biotechnology’s most promising start-ups and spotlighted 32 promising new bioscience companies.
Demand for organization’s first bond issue was more than twice the offering size.
An LA BioMed-supported study shows success in creating a new system for Human Immunodeficiency Virus (HIV) prevention.
First of its kind study identifies vaccination potential that could save 23,000 people annually.
Male Pill and Gel Would Take Steps to Prevent 40 Percent of Unplanned Pregnancies
The New England Journal of Medicine has published the results of Emmaus Life Sciences' Phase 3 clinical trial of their new sickle cell drug.